Target intelligence / Profile preview

EGFLAM antisense RNA 3 (EGFLAM-AS3)

Target: EGFLAM-AS3
Molecular classification: Long non-coding RNA (lncRNA)

Overview

EGFLAM antisense RNA 3 (EGFLAM-AS3) is a predicted long non-coding RNA (lncRNA) transcribed antisense to the protein-coding gene EGFLAM on chromosome 5p13.1[1][4][7]. There is currently no evidence that EGFLAM-AS3 has a defined biological function, protein product, disease association, or therapeutic relevance[1][4][7]. Most scientific and biomedical focus is on the protein-coding gene EGFLAM—important in synaptic function, retinal signaling, and as an emerging biomarker in cancer and other diseases[2][3]. However, EGFLAM-AS3 itself is primarily listed in gene databases without experimental characterization and is not currently considered a therapeutic target.

Beyond the preview

Go deeper on EGFLAM antisense RNA 3 (EGFLAM-AS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EGFLAM antisense RNA 3 (EGFLAM-AS3).

Explore the full profile